Skip to main content
. 2025 Jun 26;27(5):629–640. doi: 10.1007/s40272-025-00702-9

Table 3.

Final mixed model including USTE TLs, length of treatment and age of the patient at the first USTE dose

Estimate for: logF-CPT 95% CI P-value No. of observations No. of patients
Ustekinumab level (μg/mL) −0.0096 −0.0263–0.0069 0.26 249 43
Length of the treatment (days) −0.0010 −0.0015 to −0.0006 < 0.0001 249 43
Age at the first ustekinumab dose −0.0066 −0.1573–0.144 0.93 249 43

CI confidence interval; F-CPT faecal calprotectin; TLs trough levels; USTE ustekinumab